» Articles » PMID: 35625540

Making Invisible RNA Visible: Discriminative Sequencing Methods for RNA Molecules with Specific Terminal Formations

Overview
Journal Biomolecules
Publisher MDPI
Date 2022 May 28
PMID 35625540
Authors
Affiliations
Soon will be listed here.
Abstract

Next generation sequencing of RNA molecules (RNA-seq) has become a common tool to characterize the expression profiles of RNAs and their regulations in normal physiological processes and diseases. Although increasingly accumulating RNA-seq data are widely available through publicly accessible sites, most of the data for short non-coding RNAs (sncRNAs) have been obtained for microRNA (miRNA) analyses by standard RNA-seq, which only capture the sncRNAs with 5'-phosphate (5'-P) and 3'-hydroxyl (3'-OH) ends. The sncRNAs with other terminal formations such as those with a 5'-hydroxyl end (5'-OH), a 3'-phosphate (3'-P) end, or a 2',3'-cyclic phosphate end (2',3'-cP) cannot be efficiently amplified and sequenced by standard RNA-seq. Due to the invisibility in standard RNA-seq data, these non-miRNA-sncRNAs have been a hidden component in the transcriptome. However, as the functional significances of these sncRNAs have become increasingly apparent, specific RNA-seq methods compatible with various terminal formations of sncRNAs have been developed and started shedding light on the previously unrecognized sncRNAs that lack 5'-P/3'-OH ends. In this review, we summarize the expanding world of sncRNAs with various terminal formations and the strategic approaches of specific RNA-seq methods to distinctively characterize their expression profiles.

Citing Articles

Angiogenin-catalyzed cleavage within tRNA anticodon-loops identified by cP-RNA-seq.

Shigematsu M, Matsubara R, Gumas J, Kawamura T, Kirino Y Biosci Biotechnol Biochem. 2024; 89(3):398-405.

PMID: 39658364 PMC: 11840711. DOI: 10.1093/bbb/zbae192.


Immunoactive signatures of circulating tRNA- and rRNA-derived RNAs in chronic obstructive pulmonary disease.

Shigematsu M, Kawamura T, Deshpande D, Kirino Y Mol Ther Nucleic Acids. 2024; 35(3):102285.

PMID: 39220268 PMC: 11364045. DOI: 10.1016/j.omtn.2024.102285.


The tRNA half: A strong endogenous Toll-like receptor 7 ligand with a 5'-terminal universal sequence signature.

Pawar K, Kawamura T, Kirino Y Proc Natl Acad Sci U S A. 2024; 121(19):e2319569121.

PMID: 38683985 PMC: 11087793. DOI: 10.1073/pnas.2319569121.


Immunostimulatory short non-coding RNAs in the circulation of patients with tuberculosis infection.

Gumas J, Kawamura T, Shigematsu M, Kirino Y Mol Ther Nucleic Acids. 2024; 35(1):102156.

PMID: 38481936 PMC: 10933579. DOI: 10.1016/j.omtn.2024.102156.


Whole-transcriptome sequencing with ceRNA regulation network construction and verification in glioblastoma.

Zeng Z, Chen Y, Wen X, Geng X, Zhu Y, Hao L Am J Transl Res. 2023; 15(6):4291-4313.

PMID: 37434823 PMC: 10331694.


References
1.
Horwich M, Li C, Matranga C, Vagin V, Farley G, Wang P . The Drosophila RNA methyltransferase, DmHen1, modifies germline piRNAs and single-stranded siRNAs in RISC. Curr Biol. 2007; 17(14):1265-72. DOI: 10.1016/j.cub.2007.06.030. View

2.
Ozata D, Gainetdinov I, Zoch A, OCarroll D, Zamore P . PIWI-interacting RNAs: small RNAs with big functions. Nat Rev Genet. 2018; 20(2):89-108. DOI: 10.1038/s41576-018-0073-3. View

3.
Sarkies P, Selkirk M, Jones J, Blok V, Boothby T, Goldstein B . Ancient and novel small RNA pathways compensate for the loss of piRNAs in multiple independent nematode lineages. PLoS Biol. 2015; 13(2):e1002061. PMC: 4323106. DOI: 10.1371/journal.pbio.1002061. View

4.
Ha M, Kim V . Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2014; 15(8):509-24. DOI: 10.1038/nrm3838. View

5.
Gunawardane L, Saito K, Nishida K, Miyoshi K, Kawamura Y, Nagami T . A slicer-mediated mechanism for repeat-associated siRNA 5' end formation in Drosophila. Science. 2007; 315(5818):1587-90. DOI: 10.1126/science.1140494. View